“Attention NEM Investors: Take Action Now with Robbins Geller Rudman & Dowd LLP for Potential Loss Recovery Against Newmont Corporation”

The Newmont Corporation Securities Class Action Lawsuit: What You Need to Know Overview SAN DIEGO, Feb. 13, 2025 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Newmont Corporation (NYSE: NEM) securities between February 22, 2024 and October 23, 2024, inclusive (the “Class Period”), have until April 1, 2025…

Read More

US Officials Crack Down on Bitcoin Mining Hardware Imports: Report

Bitcoin Miners in the US Face Growing Uncertainty Bitcoin miners in the US are facing increasing uncertainty as customs detainments of foreign ASICs, Application-Specific Integrated Circuits, continue to rise. This has become a major concern for individuals and companies involved in cryptocurrency mining operations across the country. The Challenge of Customs Detainments ASIC devices are…

Read More

Remitly’s 2024 Financial Year-End: Get Ready for the Big Reveal on February 19, 2025!

Remitly’s Q4 and Full Year 2024 Financial Results: What You Need to Know Seattle, WA – February 5, 2025 Remitly Global, Inc. (RELY), a leading digital financial services company, recently announced that it will be releasing its fourth quarter and full year 2024 financial results. This announcement comes after the market closes on Wednesday, February…

Read More

“Calling All Investors: Bronstein, Gewirtz & Grossman LLC Launches Investigation into Business and Professional Services Industry”

Investigation into FMC Corporation New York, NY / ACCESS Newswire / February 17, 2025 Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of FMC Corporation (“FMC” or “the Company”) (NYSE:FMC). Investors who purchased FMC securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site….

Read More

Central Bankers Work to Recast Rate Expectations, But Market Optimism Remains Strong

Last week’s financial markets were characterized by a mix of resilience, speculation, and divergent central bank signals In the US, the narrative remained steadfast with Fed officials emphasizing a patient approach towards monetary policy Firmly pushing back against the market’s eager anticipations for imminent rate cuts This cautious did little to dampen the spirits of…

Read More

Revolutionary Results: Longeveron Unveils Long-Term Survival Data for Lomecel-B in HLHS Patients at CHSS 51st Annual Meeting

Clinical Study Shows Promising Results for Patients with HLHS Longeveron Inc. announces positive long-term survival data An oral presentation at the Congenital Heart Surgeons’ Society 51st Annual Meeting revealed exciting findings from a follow-on study to the ELPIS I Phase 1 clinical trial. The study highlights that patients treated with Lomecel-BTM experienced 5-year survival rates…

Read More